Zydus receives USFDA approval for generic Indocyanine Green for Injection
Dr Sharvil Patel says the approval expands Zydus’ portfolio of injectable and imaging products and supports its focus on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Zydus Lifesciences, Sunshine Healthcare sign JV to set up pharma facility in Sri Lanka
The facility, to be located at the Board of Investment zone in Horana, will be developed on nearly four acres of land, an an…
Zydus to acquire Assertio in all-cash tender offer
Assertio is focused on specialty and oncology supportive-care therapies
Zydus receives approval to conduct Phase III trials of Zintrodiazine for malaria in India
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections
Zydus expands companion diagnostics portfolio with launch of AI-powered Continuous Glucose Monitor
Zydus Lifesciences, an innovation-led global life sciences company, today announced its new offering companion diagnostics…
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg in India
Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic therapy
USFDA grants orphan drug designation to Zydus’ Desidustat for sickle cell disease
Designation covers oral HIF-PHI therapy for SCD
Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha’, in India to treat multiple…
Zydus Lifesciences, an innovation-led life-sciences company with an international presence has launched the world’s first…
Zydus Lifesciences signs licensing deal with Formycon
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lifesciences will commercialise the product in the USA…